Radiology Groups: Recommended Mammogram Guidelines Will Increase Breast Cancer Deaths
If the task force's recommendations are adopted in payment policies by the Centers for Medicare and Medicaid Services and private insurers, millions of dollars in billable tests would not be performed, hitting the imaging industry at a point when it is already absorbing reimbursement cuts from CMS.
A statement from the Access to Medical Imaging Coalition (AMIC), which represents physicians, equipment manufacturers, patient groups, and those who develop imaging technology, said the guidelines seem to go against President Barack Obama's stated goals to increase efforts in early disease detection.
"Unfortunately, Medicare has already refused to cover new technologies to increase the detection of colon cancer, is cutting payments for advanced diagnostic tests such as MRI of the breast by 50%, and now the USPSTF is paving the way for insurers to deny mammography coverage," said Tim Trysla, AMIC executive director.
"This type of policy, which puts millions of women of all ages at risk, is contrary to the evidence and the President's own words, makes no sense, and should be rejected," he said.
The recommendations were issued in a paper published today in the Annals of Internal Medicine, the journal of the American College of Physicians, and was published by the Agency for Healthcare Research and Quality.
The guidance represents a significant departure from the task force's recommendations from 2002, which suggested mammography screening—with or without clinical breast examination—every one to two years for women 40 years of age or older.
They also go against recommendations from the American Cancer Society on breast cancer screening.
The task force's 16 members are appointed by the U.S. government and work with the Agency for Healthcare Research and Quality to review the evidence of effectiveness and develop recommendations for clinical preventive services.
The task force's review concluded there's inadequate evidence that more frequent mammography carries life-saving benefits. Rather, it concluded, potential harm from screening may result, including "psychological harms, unnecessary imaging tests and biopsies in women without cancer, and inconvenience due to false-positive screening results."
The task force also referred to "the harms associated with treatment of cancer that would not become clinically apparent during a woman's lifetime (overdiagnosis), as well as the harms of unnecessary earlier treatment of breast cancer that would have become clinically apparent, but would not have shortened a woman's life. Radiation exposure (from radiologic tests), although a minor concern, is also a consideration."
The task force said women who are at high risk for breast cancer and are between the ages of 40-49 should talk with their doctor about the best time to start regular, biennial screening mammography.
Among other highlights of its report, the task force said there isn't enough evidence to assess benefits or harms of digital mammography or magnetic resonance imaging instead of film mammography.
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- Readmissions: No Quick Fix to Costly Hospital Challenge
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- 4 Tips for Managing Employed Physicians
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- House Calls Key to Pioneer ACO Success
- Providers Ask HHS to Address EHR Interoperability Barriers